Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies
Table 1
Molecular docking results of phytochemicals isolated from W. somnifera against four different proteins expressed during breast cancer.